MDMG OPENS A NEW ONCOLOGICAL CARE CENTRE

4 October 2021, Moscow – MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), a leading Russian private healthcare provider, announces the opening of a second outpatient Oncological Care Centre. 

The outpatient Oncological Care Center has been operating since the end of September and is situated in Mozhaisk, a district center of the Moscow Region, and is located inside the Mozhaisk Central Hospital. The total area of the center is 450 sq. m. This is the second center of the Group with a similar specialization. The first center has been functioning inside the Lapino-2 clinical hospital since the first quarter of 2021.

The new center provides verification of the diagnosis and referral for treatment for patients with oncology issues. The center has the following services – consultations by an oncologist, functional diagnostics, ultrasound scan, endoscopy (gastroscopy, colonoscopy), radiodiagnosis, a procedure room. If necessary, patients can receive effective oncology drug therapy in a daytime in-patient ward.

Total investment in the project amounts to 60 million rubles. Planned admission - 60 patients per shift. Medical services at the center are provided only under the MHI program.

Mark Kurtser, CEO of MD Medical Group, said: "We are continuing to expand our medical network in one of the most dynamically developing regions of Russia - the Moscow region and are focusing on oncology. By opening our new center in Mozhaisk we are providing access to high quality oncological care for residents of one of the distant districts of the Moscow region. After consultations with our doctors in Mozhaisk patients may be directed for additional check-ups or treatment at our Lapino hospital which provides chemotherapy or necessary surgery on a high medical level also in the format of the MHI program".relation to GDRs.